JP2009536182A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536182A5
JP2009536182A5 JP2009508423A JP2009508423A JP2009536182A5 JP 2009536182 A5 JP2009536182 A5 JP 2009536182A5 JP 2009508423 A JP2009508423 A JP 2009508423A JP 2009508423 A JP2009508423 A JP 2009508423A JP 2009536182 A5 JP2009536182 A5 JP 2009536182A5
Authority
JP
Japan
Prior art keywords
peptide
citrullyl
sequence
residue
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009508423A
Other languages
English (en)
Japanese (ja)
Other versions
JP5377288B2 (ja
JP2009536182A (ja
Filing date
Publication date
Priority claimed from FR0603956A external-priority patent/FR2900657B1/fr
Application filed filed Critical
Publication of JP2009536182A publication Critical patent/JP2009536182A/ja
Publication of JP2009536182A5 publication Critical patent/JP2009536182A5/ja
Application granted granted Critical
Publication of JP5377288B2 publication Critical patent/JP5377288B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009508423A 2006-05-03 2007-05-03 慢性関節リウマチの治療に有用な、マクロファージの活性を調整するペプチド Expired - Fee Related JP5377288B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR06/03956 2006-05-03
FR0603956A FR2900657B1 (fr) 2006-05-03 2006-05-03 Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
PCT/FR2007/000758 WO2007125226A2 (fr) 2006-05-03 2007-05-03 Peptides modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoïde

Publications (3)

Publication Number Publication Date
JP2009536182A JP2009536182A (ja) 2009-10-08
JP2009536182A5 true JP2009536182A5 (enExample) 2010-06-17
JP5377288B2 JP5377288B2 (ja) 2013-12-25

Family

ID=37401063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009508423A Expired - Fee Related JP5377288B2 (ja) 2006-05-03 2007-05-03 慢性関節リウマチの治療に有用な、マクロファージの活性を調整するペプチド

Country Status (8)

Country Link
US (1) US9388226B2 (enExample)
EP (1) EP2026830B1 (enExample)
JP (1) JP5377288B2 (enExample)
CA (1) CA2650864C (enExample)
DK (1) DK2026830T3 (enExample)
ES (1) ES2392882T3 (enExample)
FR (1) FR2900657B1 (enExample)
WO (1) WO2007125226A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009540847A (ja) * 2006-06-26 2009-11-26 ディーエスエム アイピー アセッツ ビー.ブイ. ペプチジルアルギニンデイミナーゼ、およびシトルリン化タンパク質およびペプチド生成におけるその使用
US20110195437A1 (en) * 2008-08-04 2011-08-11 Synmed Research Gmbh Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system
US9975944B2 (en) 2013-03-12 2018-05-22 Tel Hashomer Medical Research Infrastructure And Services Ltd. Synthetic peptides for the treatment of autoimmune diseases
FR3108515B1 (fr) * 2020-03-26 2022-03-25 Ct Hospitalier Universitaire Toulouse Colonne d’aphérèse pour le traitement de la polyarthrite rhumatoïde
FR3120877B1 (fr) * 2021-03-19 2025-03-14 Univ Toulouse 3 Paul Sabatier Cellule immunitaire comprenant un récepteur Fc à sa surface, et sur lequel est greffé une molécule hybride comprenant un fragment Fc d’anticorps et au moins un peptide citrulliné dérivé de la fibrine, et ses utilisations
JPWO2024057793A1 (enExample) * 2022-09-13 2024-03-21

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2155899A (en) * 1997-11-28 1999-06-16 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
FR2795735B1 (fr) 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
WO2002048180A2 (de) 2000-12-12 2002-06-20 Fibrex Medical Research & Development Gmbh Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
GB0030309D0 (en) 2000-12-12 2001-01-24 Univ Aberdeen Antibodies,Peptides,Analogs and uses thereof
WO2006048556A1 (fr) * 2004-11-04 2006-05-11 Biomerieux Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyartrhite rhumatoide, et leurs utilisations

Similar Documents

Publication Publication Date Title
JP2009536182A5 (enExample)
Shabgah et al. Interleukin-22 in human inflammatory diseases and viral infections
JP2012021001A5 (enExample)
JP2014518883A5 (enExample)
AR063384A1 (es) Agentes terapeuticos a base de peptidos derivados de toxinas
JP2007045828A5 (enExample)
JP2009539349A5 (enExample)
JP2012070740A5 (enExample)
CY1122242T1 (el) Ετερολογα πολυπεπτιδια il-17a/f
JP2015509091A5 (enExample)
JP2010531139A5 (enExample)
JP2017510542A5 (enExample)
RU2016128557A (ru) МЕТОДЫ И КОМПОЗИЦИИ, СВЯЗАННЫЕ С p62 / SQSTM1, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ВОСПАЛЕНИЕМ
TW200716748A (en) Toxin peptide therapeutic agents
JP2011087580A5 (enExample)
JP2017522325A5 (enExample)
JP2020520662A5 (enExample)
JP2014519522A5 (enExample)
JP2010528008A5 (enExample)
JP2014521313A5 (enExample)
JP2018198596A5 (enExample)
WO2005030196A3 (en) Methods of treating autoimmune diseases using il-21
JP2008501716A5 (enExample)
JP2013513377A5 (enExample)
JP2014511680A5 (enExample)